OLENPHOGY Redefines Berberine Bioavailability with Breakthrough TriPhasic System
The Floridant/10347212

BRANDON, Fla. - Floridant -- OLENPHOGY announced the nationwide availability of its innovative TriPhasic Berberine complex, introducing a multi-stage delivery architecture engineered to resolve the traditional absorption and gastrointestinal limitations of standard berberine supplements.

While standard Berberine HCl is widely recognized for supporting healthy blood glucose, insulin sensitivity, and AMPK activation, conventional formulations suffer from poor intestinal bioavailability—often below 5%—frequently triggering stomach discomfort. OLENPHOGY addresses these challenges by orchestrating a 3-stage delivery mechanism combined with advanced metabolic and GI-soothing co-factors:

• Phase 1 (Immediate Activation - 98% Pure DHB): Delivers Dihydroberberine (DHB), an active metabolite offering 5x greater absorption than standard berberine to rapidly optimize glucose pathways.
• Phase 2 (Classic Metabolic Support - 97% Berberine HCl): Supplies high-purity Berberine HCl to provide foundational, research-backed glycemic and AMPK support.
• Phase 3 (Sustained Precision Delivery - Liposomal Berberine): Utilizes lipid encapsulation—achieving up to 9x higher absorption—to ensure complete, gradual release while eliminating intestinal irritation.
• Advanced Glycation & GI Defense: Enhanced with Benfotiamine (fat-soluble Vitamin B1) to protect against advanced glycation end-products (AGEs) and High-Gingerol Ginger Root Extract (5%) for superior digestive comfort.

"Traditional berberine forces consumers to choose between limited bioavailability and stomach irritation," said Dr. Marcus Lin, Director of Clinical Research. "Our TriPhasic system delivers steady, high-efficiency metabolic support across all phases of absorption without compromising digestive comfort."

More on The Floridant

• New Website – Reduceregens.com
• TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
• Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
• Your Pad Thai Just Got a Stock Ticker
• Support hands-on agricultural education for children and families at upcoming gala

The clean-label formula is 100% vegan, non-GMO, allergen-free (gluten, soy, dairy-free), third-party lab tested, and manufactured in a U.S. cGMP-compliant facility without artificial fillers.

For more information, visit: https://olenphogy.com/products/triphasic-berberine

About OLENPHOGY:
OLENPHOGY is a U.S.-based premium wellness brand dedicated to smarter, precision-driven supplementation. Built on the principles of science, purity, precision, and efficiency, the brand develops clinically inspired formulas manufactured in cGMP-compliant facilities and validated through multi-stage quality testing to support intentional, informed wellness living.

Contact
Attn: PR Manager Hebe Lee
Email: hello@olenphogy.com
Phone: +1-888-588-6536
Website: https://olenphogy.com

More on The Floridant

• Digital Brew Unveils New Brand Identity as It Evolves into an AI Optimization Agency
• Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
• Florida's Sunshine Tax, Measured: McDonald's Prices Run 2% Above the National Median
• Fort Myers Community Concert Association Announces 2027 Season Underwriter
• Florida Fresh Porta Potty Rentals Brings Portable Restroom and Restroom Trailer Rentals to Orlando